BI-1408

CAS No. 2231075-94-6

BI-1408( —— )

Catalog No. M32808 CAS No. 2231075-94-6

BI-1408 is a modulator potent of γ secretase (IC50: 0.04 μM for Aβ42).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 331 In Stock
10MG 451 In Stock
25MG 634 In Stock
50MG 768 In Stock
100MG 977 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BI-1408
  • Note
    Research use only, not for human use.
  • Brief Description
    BI-1408 is a modulator potent of γ secretase (IC50: 0.04 μM for Aβ42).
  • Description
    BI-1408 is a potent γ secretase modulator with an IC50 of 0.04 μM for Aβ42.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Neuroscience
  • Target
    Gamma-secretase
  • Recptor
    Gamma-secretase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2231075-94-6
  • Formula Weight
    390.46
  • Molecular Formula
    C22H23FN6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(C=1N=C2C(=CC=CN2N1)C3=C(C)C=C(F)C=C3)[C@H]4CC5=C(CC4)N(CC)N=C5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gerlach K, et al. Discovery of tetrahydroindazoles as a novel class of potent and in vivo efficacious gamma secretase modulators. Bioorg Med Chem. 2018 Jul 23;26(12):3227-3241.?
molnova catalog
related products
  • YO-01027

    YO-01027 (Dibenzazepine) is a dipeptidic γ-secretase inhibitor with IC50 of 2.6 nM and 2.9 nM for APPL and Notch cleavage, respectively.

  • CB-103

    CB-103 is a orally active inhibitor of notch signaling pathway, with anti-tumor activity. CB-103 has shown the ability to block NOTCH signaling in human T cell acute lymphoblastic leukemia cancer cell lines, and?exhibits anti-tumor efficacy in GSI resistant T-ALL cell lines.

  • PEAQX

    PEAQX(NVP-AAM 077) is an effective and orally available NMDA antagonist. It can inhibit human NMDA receptors for 1A/2A(IC50: 270 nM), rather than 1A/2B(29, 600 nM).